April 27, 2024 Comments Off on New patent for Exeltis Usa drug DROSPIRENONE Posted in: Patent Added Annual Drug Patent Expirations for DROSPIRENONE Drospirenone is a drug marketed by Exeltis Usa Inc, Barr, Glenmark Pharms Ltd, Hetero Labs, Hlthcare, Jubilant Cadista, Mylan Labs Ltd, Watson Labs, Apotex,…
Source
April 27, 2024 Comments Off on New patent for Astellas drug XOSPATA Posted in: Patent Added Annual Drug Patent Expirations for XOSPATA Xospata is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are three patents protecting…
Source
